Yener, S. Et Al. 2017. Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.. Endocrine , vol.56, no.2 , 308-316.

Yener, S., DEMİR, L., Demirpence, M., BARIŞ, M. M., YILDIRIM ŞİMŞİR, I., Ozisik, S., ... ÇÖMLEKÇİ, A.(2017). Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.. Endocrine , vol.56, no.2, 308-316.

Yener, ABDULLAH Et Al. "Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.," Endocrine , vol.56, no.2, 308-316, 2017

Yener, ABDULLAH S. Et Al. "Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.." Endocrine , vol.56, no.2, pp.308-316, 2017

Yener, S. Et Al. (2017) . "Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.." Endocrine , vol.56, no.2, pp.308-316.

@article{article, author={ABDULLAH SERKAN YENER Et Al. }, title={Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.}, journal={Endocrine}, year=2017, pages={308-316} }